Not all ugly ducklings turn into swans. In the investment world, it takes a lot of skill and specialist industry knowledge to identify growing, innovative companies that will ultimately thrive. It is worth the effort, however, as investors who take an active stock-picking approach and go off the beaten track can be richly rewarded.
The investment managers of our thematic equity portfolios do just that. Their focus is narrower than that of mainstream equity funds. Deploying industry-specific knowledge accumulated over several years, they seek to unearth investment opportunities among specialist firms that tend to lie outside mainstream stocks markets.
They favour 'pure plays' over more diversified companies. That is a deliberate choice. There is, in fact, a large body of research that suggests specialist companies make for better long-term investments than larger, more diversified firms.
The problem is that such pure play firms can be hard to find in some industries. For example, autonomous vehicles – a market which is forecast to grow more than 10-fold by 2026 to USD557 billion by 20261 -- tends to be dominated by large component manufacturers with very broad business models.
One exception, which the Pictet-Robotics strategy honed in on, was Mobileye.
The Israel-based firm specialises in autonomous driving technology including machine vision systems which are trained to identify pedestrians, monitor blindspots and decode traffic lights. Mobileye estimates that it has a 70 per cent market share in the driver assistance system sector, with some form of such technology already installed in 27 million cars across the world.
In the financial world, too, computers are taking over what humans once used to do – including paying for stuff. The boom in e-payments, fuelled by consumers switching from cash to cards, attracted our Security strategy to the British payment provider Worldpay. The company – which was recently taken over by bigger US rival Vantiv – now processes over 40 billion of transactions a year across 146 countries, up from 11.5 billion payments just three years ago.
In healthcare, meanwhile, specialism is less of an problem but success can be hard to find at the right price. Drugs take a long time to develop, and results are not assured until the end. One company where our Health strategy saw the potential for success was Kite Pharma. The California-based company is a leading player in an emerging type of cancer immunotherapy, known as CAR-T, which uses the body’s own immune system to recognise and attack malignant cancer cells. The CAR-T therapy market is forecast to grow at a compound annual rate of 46.2 per cent over the next decade as the process develops and incidence of cancer continues to increase.
Specialised doesn’t have to mean very small, either. LinkedIn – whose social network today unites 433 million professionals – was part of our Digital portfolio some time before its acquisition by Microsoft for over USD26 billion two years ago. While most of LinkedIn’s own revenues came from jobseekers and recruiters, Microsoft saw the opportunity to take the business to the next level, potentially using the wealth of data from the social network to better design and target its products.
LinkedIn’s price represented a 50 per cent premium to the company’s pre-offer share level. Indeed, all of the companies mentioned in this piece became acquisition targets at a significant premium – a testament to the strength of our investment approach.
Clearly, cutting edge innovation is something that big companies can also do well and the investment managers of our thematic equity portfolios also have some investments in a number of large, well-known firms. But, equally, our approach is more focused on identifying opportunities early on by investing in smaller, specialist firms and to use these investments to improve returns. That is what sets our thematic equity portfolios apart.
Important legal information
This marketing material is issued by Pictet Asset Management (Europe) S.A.. It is neither directed to, nor intended for distribution or use by, any person or entity who is a citizen or resident of, or domiciled or located in, any locality, state, country or jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation. The latest version of the fund‘s prospectus, Pre-Contractual Template (PCT) when applicable, Key Information Document (KID), annual and semi-annual reports must be read before investing. They are available free of charge in English on www.assetmanagement.pictet or in paper copy at Pictet Asset Management (Europe) S.A., 6B, rue du Fort Niedergruenewald, L-2226 Luxembourg, or at the office of the fund local agent, distributor or centralizing agent if any.
The KID is also available in the local language of each country where the compartment is registered. The prospectus, the PCT when applicable, and the annual and semi-annual reports may also be available in other languages, please refer to the website for other available languages. Only the latest version of these documents may be relied upon as the basis for investment decisions.
The summary of investor rights (in English and in the different languages of our website) is available here and at www.assetmanagement.pictet under the heading "Resources", at the bottom of the page.
The list of countries where the fund is registered can be obtained at all times from Pictet Asset Management (Europe) S.A., which may decide to terminate the arrangements made for the marketing of the fund or compartments of the fund in any given country.
The information and data presented in this document are not to be considered as an offer or solicitation to buy, sell or subscribe to any securities or financial instruments or services.
Information, opinions and estimates contained in this document reflect a judgment at the original date of publication and are subject to change without notice. The management company has not taken any steps to ensure that the securities referred to in this document are suitable for any particular investor and this document is not to be relied upon in substitution for the exercise of independent judgment. Tax treatment depends on the individual circumstances of each investor and may be subject to change in the future. Before making any investment decision, investors are recommended to ascertain if this investment is suitable for them in light of their financial knowledge and experience, investment goals and financial situation, or to obtain specific advice from an industry professional.
The value and income of any of the securities or financial instruments mentioned in this document may fall as well as rise and, as a consequence, investors may receive back less than originally invested.
The investment guidelines are internal guidelines which are subject to change at any time and without any notice within the limits of the fund's prospectus. The mentioned financial instruments are provided for illustrative purposes only and shall not be considered as a direct offering, investment recommendation or investment advice. Reference to a specific security is not a recommendation to buy or sell that security. Effective allocations are subject to change and may have changed since the date of the marketing material.
Past performance is not a guarantee or a reliable indicator of future performance. Performance data does not include the commissions and fees charged at the time of subscribing for or redeeming shares.
Any index data referenced herein remains the property of the Data Vendor. Data Vendor Disclaimers are available on assetmanagement.pictet in the “Resources” section of the footer. This document is a marketing communication issued by Pictet Asset Management and is not in scope for any MiFID II/MiFIR requirements specifically related to investment research. This material does not contain sufficient information to support an investment decision and it should not be relied upon by you in evaluating the merits of investing in any products or services offered or distributed by Pictet Asset Management.
Pictet AM has not acquired any rights or license to reproduce the trademarks, logos or images set out in this document except that it holds the rights to use any entity of the Pictet group trademarks. For illustrative purposes only.